{
  "scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "Title: Randomised Controlled Trial Comparing Suprascapular and Interscalene Nerve Blocks in Shoulder Arthroscopy"
      },
      "Trial_Design": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Participants": {
        "score": 2,
        "evidence": "Participants were adults undergoing shoulder arthroscopy, with eligibility criteria including the use of SSNB or ISB."
      },
      "Intervention": {
        "score": 2,
        "evidence": "This study aimed to evaluate the analgesic efficacy and safety of suprascapular nerve block (SSNB) compared to interscalene brachial plexus block (ISB)"
      },
      "Objective": {
        "score": 1,
        "evidence": "This study aimed to evaluate the analgesic efficacy and safety of suprascapular nerve block (SSNB) compared to interscalene brachial plexus block (ISB) in patients undergoing shoulder arthroscopy."
      },
      "Method_Outcome": {
        "score": 1,
        "evidence": "The primary outcome was postoperative pain, measured using the Visual Analog Scale (VAS) at various time points."
      },
      "Randomisation_Allocation": {
        "score": 2,
        "evidence": "Randomisation and allocation concealment were adequately described in 15 and 16 studies, respectively."
      },
      "Blinding": {
        "score": 1,
        "evidence": "Blinding of outcome assessors was reported in all studies."
      },
      "Number_Randomised": {
        "score": 1,
        "evidence": "1255 patients were randomised, with 17 RCTs analysed."
      },
      "Number_Analysed": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Result_Outcome": {
        "score": 3,
        "evidence": "SSNB resulted in higher VAS at rest in PACU (MD = 0.56, 95% CI [0.19, 0.94], P = 0.003) and 1 hour post-operation (MD = 0.92, 95% CI [0.28, 1.57], P = 0.005), but lower VAS at 12 hours post-operation (MD = \u22120.71, 95% CI [\u22121.12, \u22120.3], P = 0.0006)."
      },
      "Harms": {
        "score": 1,
        "evidence": "SSNB had fewer complications, including Horner syndrome (P < 0.0001), numbness (P = 0.002), and dyspnea (P = 0.04)."
      },
      "Trial_Registration": {
        "score": 1,
        "evidence": "Trial registration: CRD42020205426."
      },
      "Funding": {
        "score": 0,
        "evidence": "Funding: Not specified."
      }
    },
    "total_score": 16,
    "max_score": 25
  },
  "model": "gpt-4o"
}